These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 6139800)

  • 101. The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
    Prichard BN
    Br J Clin Pharmacol; 1978 May; 5(5):379-99. PubMed ID: 26370
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions.
    Man in't Veld AJ; Van den Meiracker AH; Schalekamp MA
    Am J Hypertens; 1988 Jan; 1(1):91-6. PubMed ID: 2897200
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
    Ruddy MC; Bialy GB; Kostis JB
    Angiology; 1989 Jan; 40(1):45-50. PubMed ID: 2562912
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Vasodilation, not cardiodepression, underlies the antihypertensive effect of beta-adrenoceptor antagonists.
    Man in 't Veld AJ
    Am J Cardiol; 1991 Apr; 67(10):13B-17B. PubMed ID: 1673579
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Effects of ketanserin on peripheral vascular pressor mechanisms in essential hypertension.
    Elliott HL; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S62-6. PubMed ID: 2459518
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
    Lund-Johansen P
    Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity.
    Man in 't Veld AJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S30-45. PubMed ID: 6188918
    [No Abstract]   [Full Text] [Related]  

  • 108. [Proceedings: The effect of beta receptor treatment with pindolol on the plasma renin activity and the left-ventricular dynamics in essential hypertension].
    Nussberger J; Vetter W; Krayenbühl HP; Siegenthaler
    Schweiz Med Wochenschr; 1975 Nov; 105(44):1462-4. PubMed ID: 1215927
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Adrenergic and dopaminergic regulation of circulating beta-endorphin-like immunoreactivity in hypertension.
    Alföldi A; Simkó K; Fekete MI; Farsang C
    Acta Physiol Hung; 1991; 78(1):99-106. PubMed ID: 1763654
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.
    Gavras I; Gavras H; Brunner HR; Liang CS
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):213S-217S. PubMed ID: 37876
    [TBL] [Abstract][Full Text] [Related]  

  • 111. [Long-term utilization of beta-blockers in arterial hypertension].
    Tannenbaum H
    Nouv Presse Med; 1978 Sep; 7(31):2789-94. PubMed ID: 30966
    [No Abstract]   [Full Text] [Related]  

  • 112. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
    G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Effect of long-term prazosin treatment on certain humoral and metabolic factors in patients with primary hypertension].
    Knypl K; Brym E; Czerniewska E; Wocial B; Kuczyńska K; Chodakowska J
    Pol Tyg Lek; 1991 Jan 7-14; 46(1-3):32-4. PubMed ID: 1845664
    [TBL] [Abstract][Full Text] [Related]  

  • 115. [Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
    Salerno L; Licata G; Sparacino V; Custro N; Indovina I
    Clin Ter; 1979 Aug; 90(3):223-32. PubMed ID: 45260
    [No Abstract]   [Full Text] [Related]  

  • 116. Antihypertensive effect of intravenously and orally administered bunitrolol (Kö 1366).
    Okabayashi T; Naito S; Arakawa K
    Arzneimittelforschung; 1979; 29(9):1417-21. PubMed ID: 42418
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
    Malacco E; Mailland F; Bosisio E; Meroni R; Dagani R; Renesto E; Bevilacqua M
    Eur J Clin Pharmacol; 1986; 30(2):157-60. PubMed ID: 3709639
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The additional properties of beta adrenoceptor blocking drugs.
    Prichard BN; Tomlinson B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.